| pubmed-article:8618151 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8618151 | lifeskim:mentions | umls-concept:C0225369 | lld:lifeskim |
| pubmed-article:8618151 | lifeskim:mentions | umls-concept:C1706515 | lld:lifeskim |
| pubmed-article:8618151 | lifeskim:mentions | umls-concept:C1704640 | lld:lifeskim |
| pubmed-article:8618151 | lifeskim:mentions | umls-concept:C0086272 | lld:lifeskim |
| pubmed-article:8618151 | lifeskim:mentions | umls-concept:C0331858 | lld:lifeskim |
| pubmed-article:8618151 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8618151 | pubmed:dateCreated | 1996-6-12 | lld:pubmed |
| pubmed-article:8618151 | pubmed:abstractText | Growth of chondrocytes into a xenogeneic chondroepiphyseal matrix was investigated in an in vitro experimental model by combining viable calf chondrocytes with chick epiphyseal matrix devoid of viable chondrocytes. The chondrocytes were harvested from the wrist joints of newborn calves and cultured for 2 days. The epiphyses were harvested from the distal femurs and the proximal tibias of fetal chicks after development was arrested at 17 days by freezing. The epiphyseal specimens were prepared in four ways. These included femoral and tibial epiphyses without holes and femoral and tibial epiphyses with holes made by a laser. These epiphyseal specimens were co-cultured with calf chondrocytes for various periods. After digestion of the epiphyseal matrix, viable chondrocytes were counted in suspension. Chondrocyte division in the matrix was assessed by [3H]thymidine incorporation. The growth of calf chondrocytes into the xenogeneic chick matrix was evaluated by fluorescence microscopy on fresh thick epiphyseal sections. The percentage of viable chondrocytes in the xenogeneic epiphyseal matrix increased with culture time to a maximum at day 21. The addition of laser-drilled holes was found to extend a plateau of chondrocyte viability until day 29. A decrease in cell viability was detected at later observation points. This study demonstrates that xenogeneic matrix may serve as a morphogenetic scaffold for chondrocytic growth. | lld:pubmed |
| pubmed-article:8618151 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8618151 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8618151 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8618151 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8618151 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8618151 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8618151 | pubmed:issn | 0736-0266 | lld:pubmed |
| pubmed-article:8618151 | pubmed:author | pubmed-author:ZaleskeD JDJ | lld:pubmed |
| pubmed-article:8618151 | pubmed:author | pubmed-author:TomfordW WWW | lld:pubmed |
| pubmed-article:8618151 | pubmed:author | pubmed-author:OhlendorfCC | lld:pubmed |
| pubmed-article:8618151 | pubmed:author | pubmed-author:LewandrowskiK... | lld:pubmed |
| pubmed-article:8618151 | pubmed:author | pubmed-author:CarusoE MEM | lld:pubmed |
| pubmed-article:8618151 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8618151 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:8618151 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8618151 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8618151 | pubmed:pagination | 102-7 | lld:pubmed |
| pubmed-article:8618151 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:meshHeading | pubmed-meshheading:8618151-... | lld:pubmed |
| pubmed-article:8618151 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8618151 | pubmed:articleTitle | Repopulation of laser-perforated chondroepiphyseal matrix with xenogeneic chondrocytes. An experimental model. | lld:pubmed |
| pubmed-article:8618151 | pubmed:affiliation | Orthopaedic Research Laboratories, Massachusetts General Hospital, Boston, 02114, USA. | lld:pubmed |
| pubmed-article:8618151 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8618151 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8618151 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:8618151 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
